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Purpose: Accumulating evidence has shown a close connection between hemato-
poiesis and bone formation. Our aim was to evaluate the association between pe-
ripheral blood cell counts and bone mineral density (BMD) in a sample of post-
menopausal women. Materials and Methods: Three hundreds thirty eight healthy 
postmenopausal women who underwent BMD measurement during their health 
check-up were investigated. BMD was measured by dual energy X-ray asorptiome-
try at L1-L4 spine, femoral neck and total proximal femur. BMD was expressed as 
a T-score: among T-scores obtained from three different sites (L1-L4 spine, femo-
ral neck and total proximal femur), the lowest T-score was considered to be the 
subject’s T-score. Results: The prevalence of osteopenia and osteoporosis diag-
nosed by T-score in the study participants were 49.4% (167/338) and 5.0% (17/338), 
respectively. Peripheral blood white blood cell (WBC), red blood cell (RBC) and 
platelet counts had significant positive correlations with T-scores (p<0.001) upon 
simple linear regression analysis. A multiple linear regression analysis, after con-
trolling of confounders including age, body weight, systolic blood pressure, alka-
line phosphatase and creatinine, showed that WBC (β=0.127; standard error=0.043; 
p=0.014), RBC (β=0.192; standard error=0.139; p<0.001) and platelet (β=0.097; 
standard error=0.001; p=0.050) counts still had significant positive association with 
T-scores. Conclusion: The study results showed a positive relationship between 
blood cell counts and bone mineral density in postmenopausal women, supporting 
the idea of a close connection between hematopoiesis and bone formation. The 
study results also suggest that blood cell counts could be a putative marker for esti-
mating BMD in postmenopausal women.
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INTRODUCTION
   
Osteoporosis is a condition characterized by decreased bone mass and strength 
with increased fragility that predisposes the bone to fractures.1 Osteoporosis is 
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test. Among these women, 338 healthy postmenopausal 
women were included in this study and the remaining 286 
were excluded based on the following criteria: 1) premeno-
pausal, 2) currently being treated with hormonal replacement 
therapy and/or any medication for osteoporosis (calcium, vi-
tamin D and its derivatives, bisphosphonate or calcitonin) 
and/or thiazide diuretics, 3) history of hematologic disorder, 
liver cirrhosis, chronic renal failure, current infection or thy-
roid disease, which may affect peripheral blood cell counts 
or BMD and 4) unavailable information for the study vari-
ables. Approval for the study protocol was obtained from 
the Institutional Review Board of The Armed Forces Medi-
cal Commands (Seongnam, Korea). Informed consent was 
not obtained due to the routine nature of the information 
collected.
Data collection
At the hospital, a family physician performed a health check-
up which included a record check for medical and medica-
tion history, and recorded information about social habits 
(alcohol intake, cigarette smoking and regular exercise) us-
ing a standardized questionnaire. Patients were considered 
to partake in alcohol when they had at least two drinks per 
week; they were considered to be getting regular exercise if 
they exercised at least three times per week for at least 30 
minutes at a time. A gynecologist gathered the history of 
menstruation, hormonal replacement therapy and any other 
treatments for osteoporosis. A trained nurse measured sys-
tolic and diastolic blood pressure, body weight and height, 
and performed blood sampling after an overnight fast (≥12 
hours). In addition to a complete blood count, serum levels 
of albumin, creatinine and total cholesterol were measured 
on the same day in every study subject. 
The BMD of the lumbar spine (L1-L4), femoral neck and 
total proximal femur was measured by Dual energy X-ray 
absorpiometry (DXA) using the Prodigy Advance (GE Lu-
nar Health Care, Madison, WI, USA). The machine was cali-
brated daily with a standard phantom that was provided by 
the manufacturer. To evaluate BMD for the lumbar spine, the 
mean BMD value for L1 to L4 was used, unless the individ-
ual values for one or more of these vertebrae were spuriously 
elevated by osteophytes or sclerotic degenerative changes. 
The measurements were within the precision standard of 
≤1.0%. According to the WHO recommendations, T-scores 
were automatically calculated by software as the number of 
standard deviations below the average for young adults at 
peak bone density.10 T-scores were obtained at three differ-
most prevalent among postmenopausal women due to es-
trogen deficiency and is a major health problem in that pop-
ulation.1  
Stable bone mass is maintained through the controlled 
balance between bone resorption and bone formation. Bone 
resorption is carried out by osteoclasts that originate from 
the monocyte-macrophage lineage.1,2 New bone is formed 
by osteoblasts, cells of fibroblast-stromal cell lineage that 
produce several bone matrix proteins and synthesize a lattice 
for subsequent mineralization.1,2 Osteoblasts also tightly reg-
ulate osteoclastogenesis via their expression of receptor acti-
vator of NF-κB ligand and osteoprotegerin.1,2
Hematopoiesis is the process by which multipotent he-
matopoietic stem cells (HSCs) generate and replenish he-
matopoietic precursors and mature blood cells. The HSC is 
the central cell to hematopoiesis; it is located in the bone 
marrow cavity.3 Bone marrow, the soft tissue in the cavities 
of bones, provides a specific microenvironment for the main-
tenance, proper functioning and self-renewal of HSCs.3 In 
addition to hematopoietic tissue, bone marrow hosts other 
types of tissue, such as the bone marrow stroma. It also 
supports hematopoiesis by providing an appropriate micro-
environment and gives rise to different kinds of skeletal cells 
that contribute to bone remodeling.3 Within the stromal com-
partments, cells of osteoblastic lineage can interact with 
HSCs. It has been proposed that these are the main cell types 
responsible for regulating HSCs. They are located just next 
to the HSCs and support them by secreting various growth 
factors and adhesion molecules for hematopoiesis.4-9 
In spite of this given recent progress in understanding the 
HSC niche through the abundant evidence supporting the 
linkage between osteogenesis and hematogenesis, no study 
showing the direct interactions between the two systems has 
yet been performed. Therefore, the current study was carried 
out to investigate the association between peripheral blood 
cell counts and bone mineral density (BMD), which may re-
flect hematopoietic and osteogenic function, respectively. 
  
MATERIALS AND METHODS
　　　
Subjects
Of the 1,417 women who visited the Armed Forces Seoul 
Hospital (Seoul, Korea) for a health check-up between Jan-
uary 2005 and December 2009, 624 underwent BMD mea-
surement because they wanted to check their bone health or 
because they agreed with doctor’s recommendation for the 
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determine which independent variables were associated 
with the BMD (Table 3). Variables that were significant 
(p<0.05) in the simple linear regression models (Table 2) 
were considered confounding factors corrected for in the 
multivariate analysis. Height, body mass index and body 
fat were not taken into account in the analysis because of 
eventual problems with multicollinearity.11 As expected, a 
significant linear correlation was observed between T-scores 
and age, body weight and alkaline phosphatase (p<0.001). 
Systolic blood pressure and serum creatinine were also as-
sociated with T-scores (p<0.05). The WBC (β=0.127; stan-
ent sites (lumbar spine, femoral neck and total proximal fe-
mur), and the lowest value was used as the T-score for each 
subject. Subjects were grouped into three categories: normal 
bone mass with a T-score greater than -1.0, osteopenia with 
a T-score between -1.0 and -2.5, and osteoporosis with a T-
score of less than -2.5. All DXA measurements were per-
formed on the same machine, by the same operator, and an-
alyzed with the same software. 
Statistical analysis
Data are presented as mean values with standard deviations 
or percentages. Pearson’s correlation was used to determine 
the correlation between variables and T-scores. Simple and 
multiple linear regression analyses were used to estimate 
the association of variables of interest, including peripheral 
blood cell counts and T-scores. One-way analysis of vari-
ances was used to compare blood cell counts according to 
three groups of subjects (normal, osteopenia and osteoporo-
sis). A two-tailed p-value of <0.05 was considered statisti-
cally significant. All data were analyzed using Statistical 
Package for the Social Sciences  for Windows 13.0 (Chica-
go, IL, USA).
RESULTS
 
The baseline characteristics of the study participants are 
shown in Table 1. The mean age was 61.2±7.3 years and 
the mean T-score was -0.98±0.98. Time from menopause 
was an average of 10.8±6.7 years. The prevalences of os-
teopenia and osteoporosis as diagnosed by the T-score were 
49.4% (n=167) and 5.0% (n=17), respectively. 
The linear correlation between peripheral blood cell counts 
and T-scores is shown in the scatter plots in Fig. 1. Pearson’s 
correlation coefficients for the white blood cell (WBC) counts, 
red blood cell (RBC) counts, platelet counts and T-scores 
were 0.297, 0.266 and 0.248, respectively (all p<0.001).  
Upon simple linear regression analysis (Table 2), age, 
height, weight, body mass index, body fat, systolic blood 
pressure, alkaline phosphatase and creatinine were found to 
be associated with T-scores (p<0.05). The WBC, RBC and 
platelet counts were also significantly associated with T-
scores (all p<0.001). Social habits (including cigarette smok-
ing, alcohol drinking and regular exercise), diastolic blood 
pressure, serum albumin, fasting blood glucose and serum 
total cholesterol were not associated with T-scores (p>0.05).
Multiple linear regression analyses were performed to 
Table 1. Baseline Characteristics of Study Participants 
(n=338)
Characteristics Values
Age (yrs)   61.2±7.3
Height (cm) 157.5±4.7
Weight (kg)   57.0±7.6
Body mass index (kg/m2)   22.9±2.8
Body fat (%)   32.0±5.4
Social habits, n (%)
    Cigarette Smoking   13 (3.8)
    Alcohol drinking   94 (27.8)
    Regular exercise 167 (49.4)
Time since menopause (yrs)   10.8±6.7
Hypertension   82 (25.4)
Diabetes   21 (6.5)
Blood pressure (mmHg)
    Systolic 121.7±16.2
    Diastolic   76.1±9.7
Laboratory parameters
    Alkaline phosphatase (IU/L) 154.2±46.5
    Calcium (mg/dL)   9.27±0.32
    Phosphate (mg/dL)   3.73±0.41
    Albumin (g/dL)   4.11±0.18
    Fasting plasma glucose (mg/dL)   94.5±15.9
    Creatinine (mg/dL)   0.64±0.12
    Total cholesterol (mg/dL) 197.2±35.8
    White blood cell (×103/mm3)   4.93±1.20
    Red blood cell (×106/mm3)   4.29±0.33
    Platelet (×103/mm3) 242.5±56.9
Bone mineral density 
    Lumbar (g/cm2)   1.06±0.15 
    Femoral neck (g/cm2)   0.81±0.10 
    Total proximal femur (g/cm2)   0.87±0.11 
    T-score  -0.98±0.98
Diagnosis by T-score, n (%)
    Normal 154 (45.6)
    Osteopenia 167 (49.4)
    Osteoporosis   17 (5.0)
Values are expressed as mean±standard deviation or number. 
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Fig. 1. Scatter plots showing the linear associations between blood cell counts and T-scores. r, Pearson’s coefficient; WBC, white blood cell; RBC, red blood cell. 
Table 2. Simple Linear Regression Analyses Showing the Relationship between Variables and T-Scores
Variables β (SE) t p R2
Age -0.406 (0.007) -8.133 <0.001 0.164
Height  0.285 (0.011)  5.445 <0.001 0.081
Weight  0.338 (0.007)  6.577 <0.001 0.114
Body mass index  0.232 (0.018)  4.374 <0.001 0.054
Body fat  0.155 (0.010)  2.704   0.007 0.024
Cigarette smoking  0.014 (0.278)  0.256   0.798 0.000
Alcohol drinking  0.021 (0.119)  0.382   0.703 0.000
Regular exercise -0.044 (0.107) -0.815   0.416 0.002
Hypertension  0.080 (0.125)  1.445   0.150 0.006
Diabetes -0.071 (0.222) -1.279   0.202 0.005
Systolic blood pressure -0.113 (0.003) -1.979   0.049 0.013
Diastolic blood pressure  0.016 (0.006)  0.277   0.782 0.000
Alkaline phosphatase -0.139 (0.001) -2.566   0.011 0.019
Calcium  0.067 (0.164)  1.215   0.225 0.005
Phosphate  0.012 (0.128)  0.224   0.823 0.000
Albumin  0.091 (0.288)  1.678   0.094 0.008
Fasting plasma glucose  0.029 (0.003)  0.523   0.601 0.001
Creatinine  0.112 (0.421)  2.053   0.041 0.012
Total cholesterol  0.013 (0.001)  0.231   0.818 0.000
White blood cell  0.297 (0.042)  5.704 <0.001 0.088
Red blood cell  0.266 (0.153)  5.058 <0.001 0.071
Platelet  0.248 (0.001)  4.685 <0.001 0.061
β, standardized regression coefficient; SE, standard error; t, corresponding t values; R2, percent variance explained by each variable. 
Table 3. Multiple Linear Regression Analysis* Showing the Independent Relationship between Variables and 
T-Scores
Variables β (SE) t p VIF
Age -0.386 (0.006) -8.106 <0.001 1.101
Weight  0.268 (0.006)  5.563 <0.001 1.128
Systolic blood pressure -0.100 (0.003) -2.037   0.043 1.180
Alkaline phosphatase -0.234 (0.001) -5.008 <0.001 1.062
Creatinine  0.135 (0.362)  2.872   0.004 1.072
White blood cell  0.127 (0.043)  2.485   0.014 1.277
Red blood cell  0.192 (0.139)  3.962 <0.001 1.135
Platelet  0.097 (0.001)  1.971   0.050 1.169
*model, adjusted R2=0.382.
β, standardized regression coefficient; SE, standard error; t, corresponding t values; VIF, variance inflation factor.
0
2
4
6
8
10
12
-5 -3 -1 1 3
T-score
W
BC
 co
un
t (×
10
3 /m
m3
)
r=0.297
(p<0.001)
3
4
5
6
-5 -3 -1 1 3
T-score
RB
C 
co
un
t (×
10
6 /m
m3
)
r=0.266
(p<0.001)
0
200
100
300
400
500
-5 -3 -1 1 3
T-score
Pl
at
ele
t c
ou
nt
 (×
10
3 /m
m3
)
r=0.248
(p<0.001)
Blood Cell Counts and Bone Density
Yonsei Med J   http://www.eymj.org   Volume 52   Number 5   September 2011 743
addition, loss of osteoblasts was associated with a dramatic 
reduction of bone marrow cellularity that resulted in extra-
medullary hematopoeisis, consistent with the loss of the abil-
ity of the bone to support hematopoiesis.8 Moreover, en-
hanced signaling of the parathyroid hormone (PTH)/PTH-
related peptide receptor in osteoblasts was reported to be 
associated with an increase in osteoblast numbers and en-
hanced bone marrow HSC cellularity.4 The results of these 
studies provided convincing support for the direct role of 
osteoblasts in adult hematopoiesis. Therefore, bone metab-
olism and hematopoiesis appear to be closely associated and 
directly linked by osteoblast activity. 
In addition, there are structural changes of the bone mar-
row that may cause stem cell dysfunction during hematopoi-
esis. Loss of bone mass leads to a disruption of the micro-
architecture of the bone marrow, and the marrow space is 
replaced with fat tissue instead of HSCs.18,19 An in vitro 
study showed that the mesenchymal stem cells, the osteo-
blast precursor cells, from osteoporotic patients had de-
creased function when compared to similar cell types from 
normal subjects, and the cells had a higher adipogenic ex-
pression capacity.20,21 Therefore, bone marrow stem cell dis-
orders can be associated with bone loss and inappropriate 
hematopoiesis. Although the cause and effect relationship is 
not known, these findings are consistent with our assumption 
that bone loss and bone marrow stem cell dysfunction are 
closely linked. Our theories are plainly illustrated in Fig. 3. 
There have been several studies showing the association 
between BMD and certain types of peripheral blood cell 
counts. As a marker of protein nutrition and immune sys-
tem activation, lymphocyte count had a positive linear as-
sociation with BMD in postmenopausal women.22,23 In this 
dard error=0.043; p=0.014), RBC (β=0.192; standard er-
ror=0.139; p<0.001) and platelet (β=0.097; standard error= 
0.001; p=0.050) counts maintained a significant association 
with T-scores. 
Fig. 2. shows the mean values of peripheral blood cell 
counts according to the three groups of subjects by BMD 
(normal, osteopenia and osteoporosis). The blood cell counts 
decreased gradually along with the BMD (p<0.001), indi-
cating a positive relationship between blood cell counts and 
bone density.
DISCUSSION
   
The results of the present study indicate that peripheral 
blood WBC, RBC and platelet counts are independently as-
sociated with BMD in Korean postmenopausal women. 
This is the first report to show a significant relationship be-
tween peripheral blood cell counts and BMD. These findings 
support a possible linkage between bone metabolism and 
hematopoiesis. As we did not perform any studies to look 
into the mechanisms, elucidating the exact mechanism by 
which decreased blood cell counts are associated with de-
creased BMD was difficult in this study. Nonetheless, we 
can suggest possible several explanations for our results, as 
described below. 
Osteoblasts, the main cells involved in the formation of 
bone, play a central role in hematopoiesis.4 Osteoblasts are 
located at the endosteal bone surface, which is located just 
next to the HSCs in the bone marrow.4,9 They control HSC 
survival and differentiation by producing various hemato-
poietic growth factors, such as interleukin (IL)-6, IL-7, c-kit 
ligand, granulocyte macrophage colony-stimulating factor, 
stromal cell-derived factor-1, and macrophage inflammatory 
protein-1.12,13 They also express adhesion molecules such as 
integrins and N-cadherins, which are known to have hema-
topoietic progenitor-binding properties that facilitate the in-
teractions between osteoblasts and HSCs, resulting in an in-
crease in the number of HSCs in the bone marrow.14,15 An 
important role for osteoblasts in the regulation of HSCs 
was demonstrated by a series of ex vivo studies,5,6,16 and in 
vivo evidence of the role of osteoblasts in hematopoiesis 
has been provided by studies of targeted ablation of osteo-
blasts.8,17 The mice deficient in Cbfa1/Runx2, a transcrip-
tion factor crucial for osteoblast progression, did not devel-
op osteoblasts and had empty bone marrow, showing that 
osteoblasts are required to initiate bone hematopoiesis.17 In 
Fig. 2. Blood cell counts according to three subject groups by BMD (i.e., nor-
mal, osteopenia and osteoporosis). As BMD decreases blood cell counts 
also gradually decrease. *all three p-values for white blood cell, red blood 
cell and platelet counts are <0.001, estimated by one-way analysis of vari-
ances (ANOVA). BMD, bone mineral density; WBC, white blood cell; RBC, 
red blood cell.
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cell counts might provide additional information to aid in 
the understanding of the association between bone marrow 
stem cell function and BMD. Furthermore, other potential 
confounders including bone fracture history, reproductive 
history, income level, education background and calcium 
intake (all known to affect BMD in Korean adults31) were 
not considered in this study. Lastly, only postmenopausal 
women were included, so the findings cannot reliably ap-
plied to the general population. 
In conclusion, the results of this study show a positive re-
lationship between blood cell counts and BMD in Korean 
postmenopausal women. The study results suggest that there 
may be a close relationship between hematopoiesis and bone 
formation. Peripheral blood cell counts are easily obtained 
in any clinical setting, and may, at least in part, play a role as 
a putative marker of bone density, especially in postmeno-
pausal women. Further investigations are needed to clarify 
the underlying mechanisms and explain this association.
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